Chemours (NYSE: CC) reported Q4 EPS of $1.19, $0.22 better than the analyst estimate of $0.97. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.55 billion.

GUIDANCE:

Chemours sees FY2018 EPS of $4.95-$5.60, versus the consensus of $5.09.

For earnings history and earnings-related data on Chemours (CC) click here.